Clinical Scorecard: PTEN Modulates Alternative Splicing of Transcripts Linked to Autism Spectrum Disorder in Primary Neuronal Cells
At a Glance
Category
Detail
Condition
Autism Spectrum Disorder (ASD) with PTEN mutations
Key Mechanisms
PTEN regulates alternative splicing of ASD-susceptibility genes via interaction with splice factors such as U2AF65, independently of PI3K/AKT/mTOR pathway
Target Population
Individuals with ASD exhibiting PTEN mutations, particularly those with macrocephaly
Care Setting
Research and clinical neurology/neurodevelopmental disorder settings
Key Highlights
PTEN loss in neurons leads to global mis-splicing of transcripts linked to synaptic and gene expression regulatory processes.
Aberrant splicing affects known ASD risk genes and involves increased exclusion of exons with strong 3′ splice sites.
PTEN interacts with spliceosome components like U2AF65, modulating pre-mRNA splicing independently of PI3K/mTOR signaling.
Guideline-Based Recommendations
Diagnosis
Consider genetic testing for PTEN mutations in ASD patients, especially those with macrocephaly.
Evaluate alternative splicing patterns in neuronal cells as potential biomarkers for PTEN-related ASD.
Management
Target hyperactive mTOR signaling pathways in PTEN-ASD to address neuronal hypertrophy and excitability.
Investigate therapeutic strategies addressing splicing dysregulation in PTEN-deficient neurons.
Monitoring & Follow-up
Monitor neuronal function and morphology changes related to PTEN mutation effects.
Assess changes in gene expression and splicing profiles during disease progression or treatment.
Risks
PTEN mutations confer risk for ASD with macrocephaly and associated synaptic dysfunction.
Dysregulated splicing may contribute to multifactorial pathogenesis in PTEN-ASD.
Patient & Prescribing Data
ASD individuals with PTEN mutations and macrocephaly
Current insights focus on targeting mTOR hyperactivity and exploring modulation of splicing mechanisms; no direct pharmacologic agents targeting PTEN-related splicing defects are established.
Clinical Best Practices
Incorporate genetic screening for PTEN mutations in ASD diagnostic workup when macrocephaly is present.
Consider research protocols assessing alternative splicing alterations in neuronal cells for mechanistic understanding.
Address both PI3K/mTOR-dependent and independent pathways in therapeutic development for PTEN-ASD.
Researchers found misinformation rates ranged from 0% to 57% across platforms and topics, with higher rates reported in several TikTok studies compared with YouTube.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
